Linda Llewelyn Biography and Net Worth

Insider of Health Catalyst

Linda Llewelyn is the Chief People Officer at Health Catalyst. Linda joined Health Catalyst in June 2013 as the HR Manager. Prior to joining Health Catalyst, she worked in several industries, including medical technology, health care, and financial services in various HR leadership capacities. Linda has a Bachelor’s Degree in Psychology from the University of Utah.

What is Linda Llewelyn's net worth?: The estimated net worth of Linda Llewelyn is at least $337,268.67 as of February 18th, 2025. Ms. Llewelyn owns 85,819 shares of Health Catalyst stock worth more than $337,269 as of April 14th. This net worth evaluation does not reflect any other investments that Ms. Llewelyn may own. Learn More about Linda Llewelyn's net worth.
How do I contact Linda Llewelyn?: The corporate mailing address for Ms. Llewelyn and other Health Catalyst executives is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. Health Catalyst can also be reached via phone at (801) 708-6800 and via email at ir@healthcatalyst.com. Learn More on Linda Llewelyn's contact information.
Has Linda Llewelyn been buying or selling shares of Health Catalyst?: Linda Llewelyn has not been actively trading shares of Health Catalyst in the last ninety days. Most recently, Linda Llewelyn sold 6,441 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $5.43, for a transaction totalling $34,974.63. Following the completion of the sale, the insider now directly owns 85,819 shares of the company's stock, valued at $465,997.17. Learn More on Linda Llewelyn's trading history.
Who are Health Catalyst's active insiders?: Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.
Are insiders buying or selling shares of Health Catalyst?: During the last year, insiders at the sold shares 28 times. They sold a total of 174,722 shares worth more than $1,190,634.01. The most recent insider tranaction occured on April, 3rd when COO Daniel Lesueur sold 5,209 shares worth more than $21,617.35. Insiders at Health Catalyst own 2.5% of the company. Learn More about insider trades at Health Catalyst.
Information on this page was last updated on 4/3/2025.

Linda Llewelyn Insider Trading History at Health Catalyst

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/18/2025	Sell	6,441	$5.43	$34,974.63	85,819
1/15/2025	Sell	6,442	$5.80	$37,363.60	92,260
12/16/2024	Sell	6,442	$7.88	$50,762.96	98,702
10/15/2024	Sell	1,324	$8.16	$10,803.84	114,275
9/16/2024	Sell	1,324	$8.43	$11,161.32	115,599
8/15/2024	Sell	1,328	$6.57	$8,724.96	118,536
7/15/2024	Sell	1,290	$6.51	$8,397.90	119,864
5/15/2024	Sell	2,066	$7.00	$14,462.00	124,160
4/15/2024	Sell	2,005	$6.11	$12,250.55	126,226
1/16/2024	Sell	3,163	$10.83	$34,255.29	68,048
10/16/2023	Sell	1,161	$8.33	$9,671.13	79,731
9/15/2023	Sell	1,160	$11.01	$12,771.60	80,892
8/22/2023	Sell	737	$11.90	$8,770.30	83,536
2/15/2023	Sell	662	$13.82	$9,148.84	49,045
1/17/2023	Sell	642	$12.12	$7,781.04	49,707
12/15/2022	Sell	642	$11.00	$7,062.00	50,349
10/18/2022	Sell	648	$9.53	$6,175.44	55,217
9/15/2022	Sell	648	$10.99	$7,121.52	55,865
8/15/2022	Sell	668	$13.14	$8,777.52	57,361
7/15/2022	Sell	648	$16.06	$10,406.88	58,029
6/15/2022	Sell	648	$12.20	$7,905.60	58,677
5/16/2022	Sell	1,860	$15.87	$29,518.20	60,173
4/18/2022	Sell	2,039	$22.58	$46,040.62	62,033
3/15/2022	Sell	2,039	$21.08	$42,982.12
3/3/2022	Sell	218	$26.89	$5,862.02
2/1/2022	Sell	1,100	$30.00	$33,000.00
1/4/2022	Sell	3,234	$40.23	$130,103.82
12/6/2021	Sell	743	$37.61	$27,944.23
12/3/2021	Sell	2,200	$41.50	$91,300.00
11/1/2021	Sell	3,300	$53.60	$176,880.00
10/1/2021	Sell	3,259	$49.46	$161,190.14
9/3/2021	Sell	3,179	$54.27	$172,524.33
7/1/2021	Sell	3,260	$55.86	$182,103.60
6/3/2021	Sell	3,186	$52.77	$168,125.22	41,457
5/3/2021	Sell	3,455	$58.10	$200,735.50	42,079
4/1/2021	Sell	3,098	$47.67	$147,681.66	42,027
2/1/2021	Sell	1,717	$49.15	$84,390.55	24,104
12/1/2020	Sell	1,570	$34.99	$54,934.30	23,807
10/1/2020	Sell	2,242	$36.37	$81,541.54	27,619
9/1/2020	Sell	2,242	$31.35	$70,286.70	26,498
8/3/2020	Sell	2,242	$35.46	$79,501.32	27,619
7/1/2020	Sell	2,242	$29.42	$65,959.64	27,619
6/8/2020	Sell	1,121	$30.00	$33,630.00	26,498
6/1/2020	Sell	1,121	$26.97	$30,233.37	26,498
5/11/2020	Sell	21	$30.00	$630.00	25,398
5/1/2020	Sell	1,121	$25.43	$28,507.03	26,498
4/1/2020	Sell	1,121	$26.54	$29,751.34	26,498
3/3/2020	Sell	17,944	$28.53	$511,942.32	43,321

See Full Table

Linda Llewelyn Buying and Selling Activity at Health Catalyst

Health Catalyst Company Overview

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Today's Range

Now: $3.93

$3.63

$3.96

50 Day Range

MA: $4.65

$3.82

$5.89

2 Week Range

Now: $3.93

$3.60

$9.24

Volume

437,085 shs

Average Volume

616,952 shs

Market Capitalization

$275.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43